137 related articles for article (PubMed ID: 32371782)
1. Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients.
Badri O; Schmults CD; Karia PS; Ruiz ES
Dermatol Surg; 2021 Jan; 47(1):125-126. PubMed ID: 32371782
[No Abstract] [Full Text] [Related]
2. Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients.
Blokx WA; Smit JV; de Wilde PC; van de Kerkhof PC; Ruiter DJ; de Jong EM
Arch Dermatol; 2003 May; 139(5):671-3. PubMed ID: 12756113
[No Abstract] [Full Text] [Related]
3. Acitretin suppression of squamous cell carcinoma: case report and literature review.
Lebwohl M; Tannis C; Carrasco D
J Dermatolog Treat; 2003; 14 Suppl 2():3-6. PubMed ID: 14578092
[TBL] [Abstract][Full Text] [Related]
4. Acitretin amelioration of Acrokeratosis Paraneoplastica (Bazex Syndrome) in cases of incurable squamous cell carcinoma of the hypopharynx.
Vaynshtok PM; Tian F; Kaffenberger BH
Dermatol Online J; 2016 Sep; 22(9):. PubMed ID: 28329620
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic acrokeratosis (Bazex syndrome): unusual association with in situ follicular lymphoma and response to acitretin.
Conde-Montero E; Baniandrés-Rodríguez O; Horcajada-Reales C; Parra-Blanco V; Suárez-Fernández R
Cutis; 2017 Aug; 100(2):E3-E5. PubMed ID: 28961299
[No Abstract] [Full Text] [Related]
7. Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
Foxton G; Delaney T
Australas J Dermatol; 2011 Feb; 52(1):66-9. PubMed ID: 21332698
[TBL] [Abstract][Full Text] [Related]
8. Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects.
Smit JV; de Sévaux RG; Blokx WA; van de Kerkhof PC; Hoitsma AJ; de Jong EM
J Am Acad Dermatol; 2004 Feb; 50(2):189-96. PubMed ID: 14726871
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of acitretin in the treatment of squamous cell carcinoma of the oral cavity.
Carlesimo M; Narcisi A; Abruzzese C; Orsini D; Cortesi G; Arcese A; Bartolazzi A; Camplone G
Eur J Cancer Prev; 2011 Sep; 20(5):429-30. PubMed ID: 21799337
[No Abstract] [Full Text] [Related]
10. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.
Bavinck JN; Tieben LM; Van der Woude FJ; Tegzess AM; Hermans J; ter Schegget J; Vermeer BJ
J Clin Oncol; 1995 Aug; 13(8):1933-8. PubMed ID: 7636533
[TBL] [Abstract][Full Text] [Related]
11. Role of retinoids in skin cancer treatment and prevention.
Levine N
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S62-6. PubMed ID: 9703126
[No Abstract] [Full Text] [Related]
12. Acitretin for prophylaxis of cutaneous malignancies after cardiac transplantation.
McNamara IR; Muir J; Galbraith AJ
J Heart Lung Transplant; 2002 Nov; 21(11):1201-5. PubMed ID: 12431493
[TBL] [Abstract][Full Text] [Related]
13. Systemic retinoid therapy for chemoprevention of nonmelanoma skin cancer in a patient treated with vemurafenib.
Anforth R; Blumetti TC; Mohd Affandi A; Fernandez-Penas P
J Clin Oncol; 2012 Jul; 30(19):e165-7. PubMed ID: 22665544
[No Abstract] [Full Text] [Related]
14. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients.
George R; Weightman W; Russ GR; Bannister KM; Mathew TH
Australas J Dermatol; 2002 Nov; 43(4):269-73. PubMed ID: 12423433
[TBL] [Abstract][Full Text] [Related]
15. Multiple verrucous carcinomas treated with acitretin.
Kuan YZ; Hsu HC; Kuo TT; Huang YH; Ho HC
J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S29-32. PubMed ID: 17097363
[TBL] [Abstract][Full Text] [Related]
16. Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin.
Robertson SJ; Bashir SJ; Pichert G; Robson A; Whittaker S
Clin Exp Dermatol; 2010 Jun; 35(4):e100-2. PubMed ID: 19874360
[TBL] [Abstract][Full Text] [Related]
17. Serum Sirolimus Level Elevation Induced by Acitretin: Report of a Novel Drug-Drug Interaction.
Rossi AM; Hibler BP; Johnson-Jahangir H
J Drugs Dermatol; 2015 Jul; 14(7):747-9. PubMed ID: 26151793
[TBL] [Abstract][Full Text] [Related]
18. Acitretin-Altered Squamous Cell Carcinoma: A Pitfall in Diagnosis.
Koh WL; Oon HH; Tan WP
Dermatol Surg; 2019 Feb; 45(2):311-313. PubMed ID: 29781905
[No Abstract] [Full Text] [Related]
19. Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
Konda S; Patel VA; O'Bryan KW; Ratner D
Dermatol Surg; 2014 Jul; 40(7):807-10. PubMed ID: 24927001
[No Abstract] [Full Text] [Related]
20. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
